# A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis

> **NCT01888536** · PHASE4 · COMPLETED · sponsor: **Yungjin Pharm. Co., Ltd.** · enrollment: 182 (actual)

## Conditions studied

- Neurologic Claudication in Patients With Lumbar Spinal Stenosis

## Interventions

- **DRUG:** Limaprost
- **DRUG:** Pregabalin
- **DRUG:** Placebo(for Pregabalin)
- **DRUG:** Placebo(for Limaprost)

## Key facts

- **NCT ID:** NCT01888536
- **Lead sponsor:** Yungjin Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-10
- **Final completion:** 2014-02
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01888536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01888536, "A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01888536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*